DISRUPT aims to reduce the cancer burden and cancer health inequities in communities of Black, Indigenous, Latinx, Asian, People of Color, people with health conditions and impairments, and LGBTQ+ persons by working with these communities to co-create and build upon strategies to improve diversity in cancer clinical trials.
Citizen science is the collaboration of community members in scientific research in order to advance scientific knowledge. research projects. Community pilot projects will involve the collaboration of local community members trained as citizen scientists and early stage investigator
Get Involved. The purpose of the Studios is for Community Experts to hear about the initial plans and ideas for the DISRUPT Project, ask questions, point out potential problems, and make suggestions about the research project.
Meet our team.
DISRUPT brings together multidisciplinary teams from four New York City institutions, Mount Sinai’s Tisch Cancer Institute (TCI), Columbia’s Herbert Irving Comprehensive Cancer Center (HICCC), Montefiore Einstein Cancer Center (AECC) and The City College of New York (CCNY).
Educating and activating patients and providers and providing key information about potential clinical trials at the time of treatment decision-making will increase accruals to clinical trials, particularly of BIPOC populations.